» Articles » PMID: 26341664

Urothelial Cancer Associated 1: a Long Noncoding RNA with a Crucial Role in Cancer

Overview
Specialty Oncology
Date 2015 Sep 6
PMID 26341664
Citations 91
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Urothelial cancer associated 1 (UCA1) is a long noncoding RNA (lncRNA) which has gained more attention in recent years due to its aberrant expression in embryogenesis and a broad range of cancer tissues and cells. Importantly, multiple studies have shown that UCA1 plays oncogenic roles in tumor growth and metastasis, and it may act as a potential biomarker and therapeutic target for human cancers. However, the molecular mechanism of UCA1 in cancer initiation, progression and metastasis remains incompletely understood. Thus, gaining a better understanding of the functional mechanism of UCA1 in cancer onset and progression is of the utmost significance for evaluating the potential application of UCA1.

Results And Discussion: In this review, we discuss UCA1 expression profiling, isoform, expression regulation, biological role and mechanism for UCA1 tumor-promoting effect. We further discuss the potential clinical application of UCA1 as a promising diagnostic biomarker or therapeutic target for human cancers.

Conclusion: UCA1 functions as an oncogenic lncRNA in several malignancies, and it might become a potential biomarker or therapeutic target for human cancers.

Citing Articles

LINC01322 may serve as a potential diagnostic marker for advanced stage tumors in renal cell carcinoma patients eligible for total nephrectomy.

Maharati A, Taghehchian N, Taghavinia F, Golshan A, Aarabi A, Abbaszadegan M Biochem Biophys Rep. 2025; 40:101843.

PMID: 39886373 PMC: 11780390. DOI: 10.1016/j.bbrep.2024.101843.


Expression of Intragenic LCAL4 Long Non-Coding RNAs as a Potential Diagnostic and Prognostic Marker in Female Breast Cancer.

Behyari M, Behyari M J Family Reprod Health. 2024; 18(2):129-139.

PMID: 39011411 PMC: 11246735. DOI: 10.18502/jfrh.v18i2.15937.


The long non-coding RNAs (lncRNA) in the pathogenesis of gastric cancer cells: molecular mechanisms and involvement miRNAs.

Saleh R, Al-Hawary S, Hammoud A, Hjazi A, Abdulrazzaq S, Rajput P Mol Biol Rep. 2024; 51(1):615.

PMID: 38704760 DOI: 10.1007/s11033-024-09546-x.


Competitive endogenous RNA networks: Decoding the role of long non-coding RNAs and circular RNAs in colorectal cancer chemoresistance.

Khalafizadeh A, Hashemizadegan S, Shokri F, Bakhshinejad B, Jabbari K, Motavaf M J Cell Mol Med. 2024; 28(7):e18197.

PMID: 38506091 PMC: 10951891. DOI: 10.1111/jcmm.18197.


Endogenous retrovirus HERVH-derived lncRNA controls human trophoblast development.

Kong X, Li R, Chen M, Zheng R, Wang J, Sun C Proc Natl Acad Sci U S A. 2024; 121(12):e2318176121.

PMID: 38483994 PMC: 10962953. DOI: 10.1073/pnas.2318176121.


References
1.
Yang C, Li X, Wang Y, Zhao L, Chen W . Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells. Gene. 2012; 496(1):8-16. DOI: 10.1016/j.gene.2012.01.012. View

2.
Cao W, Wu H, He B, Zhang Y, Zhang Z . Analysis of long non-coding RNA expression profiles in gastric cancer. World J Gastroenterol. 2013; 19(23):3658-64. PMC: 3691033. DOI: 10.3748/wjg.v19.i23.3658. View

3.
Warburg O . On the origin of cancer cells. Science. 1956; 123(3191):309-14. DOI: 10.1126/science.123.3191.309. View

4.
Beyer T, Weiss A, Khomchuk Y, Huang K, Ogunjimi A, Varelas X . Switch enhancers interpret TGF-β and Hippo signaling to control cell fate in human embryonic stem cells. Cell Rep. 2013; 5(6):1611-24. DOI: 10.1016/j.celrep.2013.11.021. View

5.
Tsang W, Wong T, Cheung A, Co C, Kwok T . Induction of drug resistance and transformation in human cancer cells by the noncoding RNA CUDR. RNA. 2007; 13(6):890-8. PMC: 1869035. DOI: 10.1261/rna.359007. View